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he function of adhesion receptors in both cell adhesion
and migration depends critically on interactions with
the cytoskeleton. During cell adhesion, cytoskeletal
interactions stabilize receptors to strengthen adhesive con-
tacts. In contrast, during cell migration, adhesion proteins
are believed to interact with dynamic components of the
cytoskeleton, permitting the transmission of traction forces
through the receptor to the extracellular environment. The
L1 cell adhesion molecule (L1CAM), a member of the Ig
superfamily, plays a crucial role in both the migration of
neuronal growth cones and the static adhesion between
neighboring axons. To understand the basis of L1CAM
function in adhesion and migration, we quantiﬁed directly
T
 
the diffusion characteristics of L1CAM on the upper surface
of ND-7 neuroblastoma hybrid cells as an indication of
receptor–cytoskeleton interactions. We ﬁnd that cell surface
L1CAM engages in diffusion, retrograde movement, and
stationary behavior, consistent with interactions between
L1CAM and two populations of cytoskeleton proteins. We
provide evidence that the cytoskeletal adaptor protein
ankyrin mediates stationary behavior while inhibiting the
actin-dependent retrograde movement of L1CAM. Moreover,
inhibitors of L1CAM–ankyrin interactions promote L1CAM-
mediated axon growth. Together, these results suggest that
ankyrin binding plays a crucial role in the anti-coordinate
regulation of L1CAM-mediated adhesion and migration.
 
Introduction
 
The establishment and maintenance of neuronal connections
are essential features of nervous system function. The activity
of adhesion proteins on the cell surface is essential to both of
these processes. During development, the translocation of
the neuronal growth cone depends on adhesion proteins that
mediate the recognition of molecules in the extracellular
environment (Tessier-Lavigne and Goodman, 1996). In the
adult, many of the same adhesion proteins help maintain
axon fascicles and synaptic contacts. To function in adhesion
and migration, receptors need to regulate their distribution
and movement in the membrane. Although receptors involved
in adhesion maintain static connections between adjacent
cells, receptors that mediate cell migration must be more
dynamic, transmitting traction forces from the cell to its
environment (Harris et al., 1980). Receptor-mediated traction-
force generation depends on connections between adhesion
receptors and the cytoskeleton (Felsenfeld et al., 1996; Choquet
et al., 1997). Therefore, understanding the regulation of the
cytoplasmic interactions of adhesion receptors and the result-
ing changes in receptor movement on the cell surface is central
to characterizing their function in adhesion and migration.
A variety of adhesion receptor families have been shown to
serve as receptors for permissive, substrate-bound molecules
that promote axon outgrowth, including integrins, immuno-
globulin superfamily cell adhesion molecules (IgCAMs), and
cadherins (Kamiguchi and Yoshihara, 2001). In light of the
demonstrated role of IgCAMs in the guided growth of neuronal
processes during development (Kamiguchi and Lemmon,
2000; Rutishauser, 2000), understanding the biophysical
properties of these of proteins may provide crucial insight
into the mechanism underlying growth cone translocation.
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In the vertebrate central nervous system, L1 cell adhesion
molecule (L1CAM), a neuronal IgCAM, plays an essential
role in the guidance of descending cortico-spinal tract neu-
rons (Dahme et al., 1997; Cohen et al., 1998). L1CAM is
the founding member of a subfamily of neuronal IgCAMs
that include both vertebrate and invertebrate members
(Hortsch, 2000). L1CAM mutations in humans lead to a
variety of developmental defects, including corpus callosum
hyperplasia, mental retardation, adducted thumbs, spastic
paraplegia, and hydrocephalus (CRASH syndrome), sug-
gesting that L1CAM plays a crucial role in the development
of the central nervous system (Fransen et al., 1995). More-
over, the capacity of substrate-bound L1CAM ligands to
promote neurite extension in vitro through homophilic
binding (Lemmon et al., 1989; Kuhn et al., 1991; Felsenfeld
et al., 1994) raises the possibility that L1CAM on the
growth cone may mediate traction-force generation in a
mechanism similar to that observed for integrins in other
cell types.
The regulation of receptor distribution, movement, and
function in adhesion and migration depends on the connec-
tion between these glycoproteins and the cytoskeleton.
L1CAM and L1 family members interact with four known
cytosolic binding partners through two discrete sites in the
cytoplasmic tail, including ankyrin, components of the
clathrin AP-2 complex, ezrin, radixin, moesin (ERM) pro-
teins, and doublecortin (Zhang et al., 1998; Dickson et al.,
2002; Kizhatil et al., 2002; Schaefer et al., 2002). The bind-
ing of L1 family members to members of the ankyrin family
of cytoskeletal adaptor proteins is perhaps the best character-
ized of these interactions (Davis and Bennett, 1994; Garver
et al., 1997; Hortsch et al., 1998). The L1 family member
neurofascin binds to ankyrin through a motif that is highly
conserved among L1 family members near the carboxy ter-
minus of the cytoplasmic tail (Garver et al., 1997). The
ankyrin-binding site, mapped based on the interaction be-
tween neurofascin and ankyrin G, is comprised of a core 12-
aa motif that is essential for ankyrin binding, including a
carboxy-terminal tyrosine (QFNEDGSFIGQY; identical in
neurofascin and L1 from rat; Miura et al., 1991; Zhang et
al., 1998). In neurofascin, ankyrin binds to this motif in its
dephosphorylated state (Garver et al., 1997). Mutations at
this site in human L1CAM lead to a similar disruption in
ankyrin binding (Needham et al., 2001). However, the 
 
Dro-
sophila
 
 L1 homologue neuroglian, although requiring the
FIGQY motif for ankyrin recruitment, appears to be regu-
lated primarily through oligomerization of the extracellular
domain (Dubreuil et al., 1996). At a functional level, the
binding of ankyrin to L1 family members like neurofascin
plays a critical role in cell adhesion (Tuvia et al., 1997).
The work presented here is directed at understanding the
regulation of L1CAM function as reflected in changes in its
diffusion kinetics. Quantifying directly the movement of re-
ceptors on the upper surface of the cell provides an accurate
reflection of receptor function on the lower surface, where
cells exert traction forces during migration (Galbraith and
Sheetz, 1999). Therefore, the detailed analysis of L1CAM
kinetics in the plane of the membrane may provide crucial
insight into the mechanism underlying L1CAM function in
both axon growth during development and static adhesion
Figure 1. Wild-type or mutant rat L1CAM is 
expressed on the surface of ND7 cell lines. ND7 
cells expressing cDNA constructs encoding either 
wild-type (B) or mutant L1CAM (C and D), tagged 
with a myc epitope. Wild-type myc-tagged L1CAM 
(B) detected by indirect immunofluorescence using 
an anti-myc antibody (9E10) appears on the cell 
surface with a distribution that is similar to that of 
endogenous L1CAM expressed by the cell line 
(A; rabbit polyclonal against L1CAM). Mutant forms 
of L1CAM encoding single aa substitutions at 
tyrosine 1229 including Y1229F (C) and Y1229H 
(D) are similarly indistinguishable in distribution 
from endogenous protein. ND-7 cells also express 
ankyrin B as detected by immunofluorescence (E) 
and immunoblot (not depicted). (F) Control image 
of cells expressing wild-type L1CAM stained with 
secondary antibody alone. Bar, 10  m.T
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between mature axons. Previous work has revealed that L1
family members display two discrete diffusion rates on the
cell surface, consistent with protein that is either bound or
unbound from the cytoskeleton (Pollerberg et al., 1990;
Garver et al., 1997). However, as this work relies on pho-
tobleaching of populations of receptors, it provides no infor-
mation about the directed movement of protein in the lower
diffusion state. Here, we describe evidence for three distinct
classes of L1CAM movement on the cell surface, including
diffusing, nondiffusing with directed movement (retro-
grade), and nondiffusing without directed movement (sta-
tionary). Although the stationary state of L1CAM depends
on ankyrin binding to the L1CAM tail, retrograde move-
ment occurs under conditions that inhibit ankyrin binding
and depends on interactions between the L1CAM cytoplas-
mic tail and dynamic actin in the cytosol. Ankyrin binding
inhibits L1CAM retrograde movement, suggesting that
ankyrin may play a crucial role in effecting the switch be-
tween the stationary and directed behavior of L1CAM on
the cell surface. More significantly, peptides that inhibit
ankyrin binding stimulate L1CAM-mediated neuronal ex-
tension, suggesting that the regulation of L1CAM-mediated
traction-force generation is essential to the migration of neu-
ronal growth cones on L1CAM ligands in vivo.
 
Results
 
To begin to characterize the regulation of L1CAM–cyto-
skeleton interactions, we examined the lateral mobility of
cell surface L1CAM in cultured cell lines. Full-length rat
L1CAM including the neuron-specific RSLE exon was ex-
pressed in ND-7 cells (rat DRG/neuroblastoma hybrid;
Dunn et al., 1991) to provide a controlled background on
which to characterize L1CAM function. These adherent cells
express both endogenous L1CAM and ankyrin B (Fig. 1, A
and E). Cells were transfected transiently with a wild-type rat
L1CAM cDNA construct encoding an amino-terminal myc
epitope to permit the detection of the transgene product in
the context of endogenous L1CAM. The distribution of the
epitope-tagged protein was similar to that of endogenous
L1CAM, suggesting that mycL1CAM was appropriately
transported and distributed on the cell surface (Fig. 1, A and
B). 1-
 
 
 
m latex beads coated with an anti-myc antibody
(9E10; Evan et al., 1985) were placed and held with an opti-
cal gradient laser trap on the cell surface between 0.5 and 1
 
 
 
m from the leading edge for 2 s. To identify cells expressing
the L1CAM transgene, cells were transfected with a bi-
cistronic vector encoding both mycL1CAM and EGFP
(CLONTECH Laboratories, Inc.). mycL1CAM expression,
detected by indirect immunofluorescence, was well correlated
with EGFP expression (unpublished data). Bead binding to
the cell surface varied with antibody concentration and fell
off dramatically between 0.037 and 0.0073 mg/ml beads
(Fig. 2, white bars). Additionally, binding of beads coated
with a high concentration of 9E10 (0.58 mg/ml beads) to
cells transfected with L1CAM lacking the myc epitope was
0–20% (for each individual experiment), suggesting that
bead binding is selective for myc-tagged L1CAM on the cell
surface. Bound beads were subject to a second pulse from the
laser trap (see Materials and methods) to test the resistance of
L1CAM–bead complex to lateral displacement, a strong indi-
cator of cytoskeletal attachment (Choquet et al., 1997;
Felsenfeld et al., 1999). At the highest concentration of anti-
body (0.37 mg Ab/ml beads), the majority of beads were re-
sistant to lateral displacement (Fig. 2, black bars “rigid”). The
percentage of beads that were bound but not resistant to dis-
placement (Fig. 2, gray bars, “loose”) was inversely propor-
tional to antibody concentration. These results suggest that
extracellular oligomerization of L1CAM by antibody regu-
lates the association between L1CAM and the actin cytoskel-
eton, consistent with results from analyses of other L1 family
members (Dubreuil et al., 1996).
 
L1CAM engages in three distinct classes of movement 
on the cell surface
 
To analyze directly the behavior of L1CAM on the upper
surface of the cell, we recorded the movement of beads
bound by antibody to cell surface L1CAM. Beads coated
with 9E10 (0.58 mg/ml beads) bound to the cell surface
and underwent rapid diffusion (Fig. 3, A, D, and G), retro-
grade movement (Fig. 3, B, E, and H), or remained station-
ary (Fig. 3, C, F, and I). For diffusing beads, the trajectory
lacked any detectable directed movement with respect to
the leading edge (Fig. 3 D). Similarly, mean square dis-
placement for diffusing beads (Fig. 3 G) was linear with re-
spect to time, consistent with diffusion in the absence of di-
rected movement. The average rate of diffusion (0.082
 
 
 
m
 
2
 
s
 
 
 
1
 
; 
 
n
 
 
 
  
 
13) suggests that the random movement of
L1CAM in the bilayer occurs largely in the absence of cyto-
skeletal or other interactions that would immobilize the
protein(s) bound to the bead. In contrast, beads bound to
retrograde-moving L1CAM (Fig. 3 B) showed little or no
Figure 2. L1CAM–cytoskeleton interactions depend on L1CAM 
cross-linking. 1- m latex microspheres coated with anti-myc 
antibodies recognize cell surface L1CAM tagged with a myc epitope. 
Bead binding to the cell surface after placement with a laser trap 
(white bars indicate no binding) depended on antibody concentration. 
Once bound, beads were tested for resistance to lateral movement 
with the laser trap (see Materials and methods) as an indication of 
cytoskeletal attachment. The percentage of trials that are attached 
and rigid on the cell surface (black bars) or attached and but subject 
to displacement (gray bars) varied directly with antibody concentration.T
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diffusion, moving away from the leading edge of the cell
with a uniform velocity and direction. This directed move-
ment occurred largely in the absence of movement parallel
to the leading edge (Fig. 3 E). For all experiments, cells
were selected at a wide variety of expression levels (based on
coexpression of EGFP) to reduce the possibility of biases
that might arise from overexpression. Nonetheless, we can-
not preclude the possibility that L1CAM transgene overex-
pression may affect bead binding and lateral mobility. As
with integrins (Felsenfeld et al., 1996), retrograde move-
ment of L1CAM was often proceeded by a brief (
 
 
 
10 s),
diffusive latency period (unpublished data). The velocity
of retrograde-moving beads on cells expressing wild-type
L1CAM ranged from 0.6 to 2.2 
 
 
 
m min
 
 
 
1
 
, similar to the
velocity of other cell surface adhesion proteins (Felsenfeld et
al., 1996; Lambert et al., 2002). Therefore, the velocity and
direction of bead movement is consistent with an interac-
tion between L1CAM and treadmilling actin in the cytosol
of the lamella.
In addition to diffusion and retrograde movement, cell
surface L1CAM displayed a distinct behavior characterized
by a low rate of diffusion in the absence of detectable di-
rected movement (Fig. 3, C, F, and I). The stationary behav-
ior was transient and appeared to punctuate periods of diffu-
Figure 3. Wild-type L1CAM engages in three distinct classes of kinetic behavior on the cell surface. 1- m latex microspheres coated with 
anti-myc antibodies recognize cell surface L1CAM tagged with a myc epitope. Bound beads underwent diffusion (A, D, and G), retrograde 
movement (B, E, and H), or stationary behavior (C, F, and I). All data sets were rotated to orient the cell with its leading edge facing left. (A–C) 
Plots of X vs. Y coordinates of representative data sets (in  m) are consistent with either diffusive (diffusion coefficient D   0.11  m
2s
 1; 
v   0  m min
 1), slow directed movement (D   1.12   10
 4  m
2s
 1; v   0.924  m min
 1) or stationary behavior (D   4.18   10
 4  m
2s
 1; 
v   0  m s
 1; origin indicated by blue arrow). Stationary behavior can be observed as discrete clusters in the bead trajectory (C, black circle). 
Plots of X and Y coordinates vs. time indicated that the diffusing bead (D) shows no detectable directed movement in the axis of cell migration 
as movement perpendicular (⊥, fine trace) or parallel (ll, thick trace) to the leading edge are similarly chaotic. In contrast, beads undergoing 
retrograde movement on the cell surface show slow, uniform movement away from the leading edge with little or no displacement parallel to 
the leading edge (E). For stationary beads, in the case of the bead shown here (F), diffusive movement decreased (indicated by bars; colors 
correspond to circles in C after a period of free diffusion [ 10 s]). Mean squared displacement (MSD) for the diffusing bead was linear with 
respect to time (G), confirming that the behavior is diffusive in the absence of directed movement. The black trace reflects the measured 
MSD. The red line reflects the best fit of this curve by linear regression. For the retrograde-moving bead (H), the MSD plot has a quadratic 
shape, reflecting directed movement with substantially reduced diffusion. For stationary beads (I), MSD for the period indicated by the gray 
bar in F shows no evidence of directed movement.T
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sion (Fig. 3 C, black circle). Periods of stationary behavior
appeared as plateaus with reduced noise in plots of displace-
ment vs. time (Fig. 3 F, black line), consistent with a de-
creased rate of diffusion. Although it is difficult to analyze
the velocity from the mean square displacement for short
data segments, analysis of data sets with a high ratio of sta-
tionary behavior to diffusion (Fig. 3 C, data in gray circle;
Fig. 3 F, data over gray bar) revealed a reduced diffusion co-
efficient compared with freely diffusing particles (Fig. 3, G
and I) with little or no directed component. In cells express-
ing wild-type L1CAM, 9E10 beads underwent retrograde
transport on the cell surface in 67.9% of trials, whereas
28.6% displayed stationary behavior (Fig. 4 A). Together,
these results demonstrate that L1CAM is capable of three
distinct classes of behavior on the cell surface, including dif-
fusion, retrograde movement, and stationary behavior in the
absence of directed movement. These distinct behaviors are
consistent with interactions between L1CAM and both dy-
namic and static components of the cytoskeleton.
 
L1CAM retrograde movement depends on the L1CAM 
cytoplasmic tail and dynamic pools of actin
 
To begin to examine the mechanism underlying the directed
and stationary behavior of L1CAM on the cell surface, we
observed the movement of L1CAM in the presence of vari-
ous cytoskeletal inhibitors. Cytochalasin D, at a concentra-
tion that completely suppresses F-actin in the periphery of
ND-7 cells (2 
 
 
 
M; unpublished data), abolishes the retro-
grade movement of L1CAM (Fig. 4 A; 
 
n
 
 
 
  
 
12, P 
 
  
 
.01). In
contrast, stationary behavior was still observed in a small per-
centage of trials, suggesting that this behavior is either actin
independent or mediated by nondynamic pools of actin that
are less sensitive to cytochalasin D treatment. In contrast,
both retrograde movement and stationary behavior were ob-
served in the presence of 1 
 
 
 
M nocadazole (a concentration
that blocks microtubule polymerization in ND-7 cells; un-
published data), although the frequency of retrograde move-
ment was diminished as compared with untreated control
cells (
 
n
 
 
 
  
 
16, P 
 
  
 
.22). Treatment with DMSO alone at the
same concentration used in the dilution of cytochalasin D
and nocadazole resulted in a slight increase in retrograde
movement (perhaps due to changes in membrane fluidity).
These results suggest that retrograde movement of cell sur-
face L1CAM is actin-mediated, although microtubules may
also contribute indirectly to this process.
To determine whether the low diffusive states of L1CAM
on the cell surface are mediated directly by the L1CAM
cytoplasmic tail, we generated a truncation mutant of
L1CAM that interrupts the cytoplasmic tail with a stop
mutation 4 aa after the predicted transmembrane domain.
Beads bound to truncated L1CAM on the cell surface dif-
 
Figure 4.
 
L1CAM–cytoskeleton interactions mediate retrograde 
and stationary behaviors.
 
 Bar graphs showing the percentage of 
trials engaging in stationary behavior, retrograde movement, or 
diffusion in cells expressing either wild-type or mutant forms of 
L1CAM. (A) Wild-type L1CAM treated with actin and microtubule 
inhibitors. In ND-7 cells expressing wild-type L1CAM, 28.6% of trials 
were stationary, 61.9% retrograde, and 23.8% diffused (
 
n
 
 
 
  
 
21). 
Cytochalasin D treatment (2 
 
 
 
M) eliminated retrograde movement 
(stationary 16.7%, retrograde 0%, diffusing 83.3%; 
 
n
 
 
 
 
 
 12). In contrast, 
nocadazole treatment (1 
 
 
 
M) inhibited retrograde movement slightly 
while leaving stationary behavior and diffusion unaffected (stationary 
31.25%, retrograde 43.75%, diffusing 25%; 
 
n
 
 
 
  
 
16). Treatment with 
DMSO alone at the same concentration used to dilute cytochalasin D 
and nocadazole caused a slight increase in retrograde movement 
(stationary 22.2%, retrograde 88.8%; diffusing 11.1%; 
 
n
 
 
 
  
 
9). 
(B) L1CAM cytoplasmic tail mutants. In cells expressing an L1 mutant 
with an introduced stop codon designed to truncate the protein, 
leaving 4 aa of the predicted cytoplasmic tail (stop), the receptor 
diffused exclusively. In cells expressing the YF mutant of L1CAM 
(YF), 62.5% of trials were stationary and 37.5% were retrograde 
moving (56.2% diffused; 
 
n
 
 
 
  
 
16). In cells expressing a histidine in 
place of Y1229 (FIGQY-H; YH, a mutation that inhibits ankyrin 
binding), 0% were stationary, 92.9% were retrograde-moving and 
7.1% diffusing (
 
n
 
 
 
  
 
14). Finally, in cells expressing wild-type L1CAM 
treated with NGF to stimulate phosphorylation of Y1229, inhibiting 
ankyrin binding, 18.2% of trials displayed some form of stationary 
behavior, whereas 100% underwent retrograde transport on the cell 
surface (0% diffusing; 
 
n
 
 
 
  
 
11).T
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fused in 100% of trials (Fig. 4 B; 
 
n
 
 
 
  
 
17, P 
 
  
 
.01), suggest-
ing that both retrograde movement and stationary behavior
depend on interactions between the L1CAM cytoplasmic
tail and the cytoskeleton.
 
Mutations that affect ankyrin binding modulate 
L1CAM movement in the plane of the membrane
 
To examine directly the role of L1CAM–cytoskeleton inter-
actions in L1CAM movement on the upper surface, we in-
troduced a series of point mutations into the region of the
L1CAM tail that has been implicated in ankyrin binding.
Mutant constructs were generated encoding single aa substi-
tutions for tyrosine1229 to either phenylalanine, a mutation
that induces constitutive ankyrin binding in other vertebrate
L1 family members (L1-YF; Garver et al., 1997; Tuvia et al.,
1997), or to histidine to inhibit ankyrin binding (L1-YH; a
naturally occurring MASA mutation in humans; Garver et
al., 1997; Tuvia et al., 1997; Needham et al., 2001). Each of
these constructs was expressed in ND-7 cells and displayed
cell surface distribution comparable to that seen for wild-
type L1CAM (Fig. 1, B–D). In culture, 9E10 beads placed
on the upper surface of the cell with a laser trap bound with
a frequency similar to that seen in cells expressing wild-type
mycL1CAM. Like wild-type L1CAM, L1-YF displayed a
combination of diffusive, retrograde, and stationary behav-
iors. However, the ratio of these behaviors was different
from that of the wild-type receptor, showing an increase in
stationary behavior (62.5%) with a commensurate decrease
in retrograde movement (37.5%; Fig. 4 B; 
 
n
 
 
 
  
 
16, P 
 
 
 
.01). In contrast, beads bound to the L1-YH mutant showed
a large increase in the percentage of trials undergoing retro-
grade movement (92.9%) and a complete loss of stationary
behavior (Fig. 4 B; 
 
n
 
 
 
  
 
14, P 
 
  
 
.011). These results suggest
that L1CAM stationary behavior is mediated by ankyrin
binding, whereas the retrograde movement of L1CAM on
the cell surface is ankyrin independent.
 
Growth factor treatment inhibits ankyrin recruitment 
and L1CAM stationary behavior at the cell surface
 
To test further this hypothesis, we examined the behavior of
wild-type L1CAM (including the myc-epitope tag) after
growth factor treatment. It has been reported previously
Figure 5. Growth factor treatment 
inhibits ankyrin B binding to L1CAM. 
293 cells transfected with a cDNA 
encoding full-length rat L1CAM in the 
absence (A, C, and E) or presence (B, D, 
and F) of EGF. Ankyrin (A and B) and 
L1CAM (C and D) were detected by 
indirect immunofluorescence in double-
labeled confocal sections through cell 
aggregates to permit the visualization 
of L1CAM and ankyrin B at the cell 
membrane. (E) Combined micrographs 
indicating ankyrin staining (red) and 
L1CAM staining (green) reveal clear 
codistribution of signal in the absence of 
EGF. In contrast, in the presence of EGF 
(F), L1CAM staining remains at the 
membrane, but ankyrin B staining is 
largely absent, appearing in a more 
uniform distribution throughout the 
cytosol. (G) Direct quantification shows 
a significant reduction of ankyrin B 
colocalization with L1CAM at the 
membrane in the presence of EGF
(mean   SD; P   0.01). (H) The method 
for quantifying ankyrin B localization to 
the membrane uses densitometry of a 
line scan (red) across a cell–cell junction 
where L1CAM is expressed (ankyrin B 
staining is shown here). The resulting 
intensity profile is used to determine a 
minimum signal for comparison to the 
value of the ankyrin B signal at the point 
where the maximum signal in the L1CAM 
channel occurs. These values are 
combined to give an index value using 
the equation index   (max min)/min. 
Index values were averaged and 
normalized with respect to the control 
values. Error bars   SD. Bar, 10  m.T
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that tyrosine phosphorylation of L1 family members at the
FIGQY motif is modulated by activation of a variety of
membrane-linked tyrosine kinase receptors, including re-
ceptors for NGF, FGF, EGF (Garver et al., 1997), and by
the Eph kinase Cek5 (Zisch et al., 1997). L1CAM-trans-
fected 293 cells recruited ankyrin to the membrane in an
L1CAM-dependent manner (Fig. 5, A, C, and E). Treat-
ment of these cells with EGF (50 ng/ml; 1 h) inhibited
ankyrin membrane localization (Fig. 5, B, D, and F), similar
to the behavior of other L1 family members (Zhang et al.,
1998) and consistent with a phosphorylation-dependent in-
hibition of L1CAM–ankyrin binding. Measurement of
ankyrin immunolocalization along a line drawn across the
junction of L1CAM-positive cells (Fig. 5 H; Oancea et al.,
1998) demonstrates a quantifiable and significant change in
ankyrin–membrane association (Fig. 5 G; P 
 
  
 
.01). Similar
results were obtained using ND-7 cells treated with NGF
(unpublished data), suggesting that these cells, derived from
primary sensory neurons, have maintained their sensitivity
to NGF.
Treatment of ND-7 cells expressing myc-tagged wild-type
L1CAM with NGF caused a shift in the ratio of stationary
to retrograde-moving beads similar to that seen in cells ex-
pressing L1-YH (18.2% stationary, 100% retrograde; Fig. 4
B; 
 
n
 
 
 
 
 
11, P 
 
  
 
.02; for some trials, beads exhibited both
forms of behavior). Together, these results suggest that
L1CAM–ankyrin interactions mediate the stationary behav-
ior of cell surface L1CAM. Moreover, the increase in the
percentage of beads undergoing retrograde movement in
conditions that perturb ankyrin binding raises the possibility
that ankyrin may negatively modulate L1CAM-mediated
traction-force generation.
 
Peptides derived from the L1CAM tail inhibit ankyrin 
binding and stationary behavior by L1CAM 
on the cell surface
 
To examine independently the role of ankyrin binding in
the directed movement of L1, we designed peptides directed
at inhibiting L1–ankyrin interactions in live cells. The in-
hibitory peptide is a fusion between the ankyrin-binding re-
gion of the L1CAM tail and the membrane-permeable pene-
tratin domain of antennapedia (Derossi et al., 1998). The
inhibitory region of this peptide was derived from the 12-
aa conserved ankyrin-binding domain of the L1CAM tail
(Zhang et al., 1998) including a Y to F substitution
(QFNEDGSFIGQF; AP-YF). Peptide activity was com-
pared with that of a peptide in which the inhibitory se-
quence was reversed (AP-Scramble).
To test the function of the AP-YF in situ, we examined
its capacity to inhibit L1CAM-mediated recruitment of
ankyrin to the cell membrane. In the presence of peptide
AP-YF, ankyrinB was almost entirely absent from sites of
cell–cell contact (Fig. 6 A). In contrast, in the absence of
peptide or in the presence of the control, scrambled peptide,
ankyrinB appeared at the cell membrane where L1CAM was
expressed (Fig. 6 A; unpublished data). Quantification of
ankyrin colocalization with L1CAM at the membrane re-
vealed a significant reduction in the junctional distribution
of ankyrin in AP-YF–treated cells (Fig. 6 A; P 
 
  
 
0.01).
These results suggest that the AP-YF peptide is an effective
inhibitor of L1CAM–ankyrin interactions in live cells.
As was the case with the L1-YH mutation, the AP-YF in-
hibitory peptide reduced the percentage of beads showing sta-
tionary behavior on the cell surface with an accompanying in-
crease in the percentage of trials undergoing retrograde
movement (Fig. 6 B; 
 
n
 
 
 
  
 
18, P 
 
  
 
.05). Cells treated with the
control, AP-Scramble peptide behaved in a manner similar to
untreated cells, although there may be a slight (though not
significant) increase in retrograde movement (
 
n
 
 
 
  
 
9; P 
 
 
 
.05). These results confirm that experimental treatments that
interfere with L1CAM–ankyrin binding inhibit selectively
Figure 6. FIGQF peptides inhibit L1CAM–ankyrin interactions, 
stationary behavior of cell surface L1CAM, and increase the velocity 
of L1CAM retrograde movement. Peptides derived from the sequence 
of the ankyrin-binding domain of L1CAM conjugated to the 
membrane-permeant domain of antennapedia (AP-YF; see text) 
inhibit L1CAM–ankyrin interactions in membrane recruitment 
assays (A; P   0.01). Scrambled peptides (AP-Scramble) where the 
ankyrin-binding domain is reversed have no detectable effects on 
L1CAM–ankyrin interactions. (B) Quantification of bead movement 
shows that the AP-YF peptides inhibit the stationary behavior of 
beads bound to cell surface L1CAM as compared with treatment 
with either AP-Scramble peptide or control (untreated) conditions. 
(C) AP-YF peptides also increase the mean velocity of retrograde 
movement by approximately twofold as compared with either AP-
Scramble (P   0.01) or control conditions (P   0.01). A similar 
increase in the velocity of bead movement is observed using L1CAM 
mutants that inhibit ankyrin binding (FIGQH; Y1229-H substitution; 
P   0.01). Error bars   SD.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
726 The Journal of Cell Biology | Volume 162, Number 4, 2003
the low diffusion stationary state observed in wild-type
L1CAM on the cell surface. This observation strongly sug-
gests that ankyrin mediates L1CAM interactions with station-
ary components of the cytoskeleton. Moreover, the increase
in the percentage of trials undergoing retrograde movement
on the cell surface after inhibition of L1CAM–ankyrin inter-
actions raises the possibility that ankyrin binding may also in-
hibit the directed movement of L1CAM on the cell surface.
To address this question, we quantified the velocity of
bead movement in trials undergoing translocation on the
cell surface in the presence of AP-YF or control peptides.
Cells cultured in the presence of inhibitory peptide showed,
on average, a twofold increase in the velocity of L1CAM-
directed movement on the cell surface as compared with cells
treated with control peptide (Fig. 6 C; P   0.01) or un-
treated cells (P   0.01). The movement of L1CAM in the
presence of control peptide was largely unaffected. Similarly,
analysis of mutant L1-YH, which is also deficient in ankyrin
binding, displays a significant increase in the rate of directed
protein movement on the cell surface as compared with un-
treated cells expressing wild-type L1CAM (P   0.01). The
change in mean velocity does not merely reflect the decrease
in the percentage of stationary beads, as beads with a mean
velocity of 0 were not included in the calculated average ve-
locity. Together, these results implicate L1CAM–ankyrin
interactions in the regulation of L1CAM-directed move-
ment on the cell surface.
Inhibitors of ankyrin binding stimulate 
L1CAM-mediated neurite outgrowth
The changes in bead kinetics on the upper surface of the cell
raise the possibility that the role of ankyrin binding in vivo
may be to differentially regulate the adhesion and migration
of growing neurons. To address this question directly, we
cultured mouse cerebellar granular neurons in the presence of
either inhibitory AP-YF or control peptides (Fig. 7). These
neurons use cell surface L1CAM as the primary receptor for
substrate-bound L1CAM ligands (Dahme et al., 1997), per-
Figure 7. Peptide inhibitors of L1CAM–
ankyrin interactions selectively stimulate 
L1CAM-mediated neuronal growth. 
Cerebellar cells prepared from P4 mouse 
(1.25   10
5 cells) were plated on chick 
NgCAM (A and B) or on mouse laminin 
(C and D). Cultures were fixed after 24 h 
and images were collected. Cultures 
were treated with either AP-YF (A and C) 
or AP-Scramble (B and D) peptides. 
Measured cell numbers are 105 (lami-
nin   AP-YF), 106 (laminin   AP-Scram-
ble), 322 (NgCAM   AP-YF), and 273 
(NgCAM   AP-Scramble). Bar, 125  m. 
(E) The percentage of neurons (y-axis, %) 
with neurites greater than length X 
(x-axis,  m). Note that treatment of
neurons on NgCAM substrates with
AP-YF peptide (closed circle) shifted the 
profile plot to the right compared with 
control treatment with AP-Scramble
peptide (open circle), whereas peptide 
treatment did not affect profile plot of 
laminin substrate (squares). Control (BSA) 
substrate did not promote neurite 
extension (x). (F) Bar graph showing 
mean neurite length ( m; error bars 
represent SEM) for neurons grown under 
each condition (indicated at bottom).T
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mitting us to test directly L1CAM function in neurite exten-
sion. Neurons grown on NgCAM, a chick homologue of
L1CAM, extend 21  m (  2) after 24 h in culture in the
presence of control peptides. In contrast, neurons cultured
in the presence of AP-YF extend 55% above control levels
(32   2  m; P   0.01). Axon extension on laminin, which
promotes outgrowth through interactions with cell surface
integrins (Felsenfeld et al., 1994), was not significantly af-
fected by peptide treatment (P   0.05). These results suggest
that L1CAM-dependent neuronal growth is modulated by
changes in L1CAM–ankyrin interactions. Additionally, these
results support the idea that traction-force generation in the
neuronal growth cone plays a role in neurite extension.
Discussion
Here, we have presented evidence for multiple, discrete
modes of kinetic behavior for L1CAM in the lipid bilayer,
consistent with the roles of L1CAM in adhesion and migra-
tion. L1CAM function, as detected by changes in the diffu-
sion kinetics of L1CAM in the bilayer, depends on at least
two distinct interactions between L1CAM and the cytoskele-
ton, a conclusion supported by the following observations.
First, stationary behavior is exquisitely sensitive to mutations
and treatments that inhibit ankyrin binding, suggesting that
ankyrin is a primary mediator of this activity. Second,
L1CAM retrograde movement is completely inhibited by cy-
tochalasin D or L1CAM cytoplasmic tail truncations, indicat-
ing that dynamic actin at the front of the cell drives L1CAM
force generation. Third, treatments that inhibit ankyrin bind-
ing activate retrograde movement. Finally, ankyrin binding
appears to play a role in regulating axon extension, raising the
possibility that an increase in receptor retrograde movement
on the cell surface is directly linked to cell motility.
Both retrograde and stationary behaviors depend on the
interactions of the L1CAM cytoplasmic tail. L1CAM trun-
Figure 8. Model describing the regulation of L1CAM dynamics and function by ankyrin binding. (A) Schematic diagram illustrating the 
leading edge (lamella) of a cell in profile (gray) spread on a two-dimensional surface (black line with crosshatching). Cell is oriented toward 
the right-hand edge of the page. Treadmilling actin in the lamella of the cell (indicated by yellow chevrons and arrow) provides the force for 
moving cell surface glycoproteins like L1CAM (light blue) in a retrograde direction on the cell surface. The movement of L1CAM in the plane 
of the membrane is monitored by beads bound to L1CAM on the upper surface of the cell through a selective antibody (green). (B) Expanded 
view of area indicated by box in A. Ankyrin-binding domain of L1CAM (light blue) is indicated by oval in cytoplasmic tail. L1CAM–ankyrin 
interactions mediate the static behavior of L1CAM on the upper surface of the cell. This may be accomplished through ankyrin (red) binding 
to the membrane/spectrin cytoskeleton. Additionally, L1CAM interacts with dynamic components of the cytoskeleton, presumably treadmilling 
actin (yellow). These interactions offer a potential explanation for the distinct classes of L1CAM movement that we have observed. The indirect 
interaction between L1CAM and treadmilling actin in the absence of ankyrin binding results in the retrograde movement of cell surface L1CAM 
(i). In contrast, ankyrin binding in the absence of interactions with treadmilling actin gives rise to L1CAM that remains stationary on the cell 
surface (iii). Finally, both interactions together (ii) results in a regulated traction force generation where ankyrin binding modulates the ankyrin-
independent generation of traction forces through cell surface L1CAM (smaller black arrow).T
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cation mutants (Stop) diffuse freely on the cell surface, dem-
onstrating that the L1CAM cytoplasmic domain is crucial
for these phenomena, and suggesting that cis interactions
with other receptors in the bilayer contribute little to the re-
stricted movement of L1CAM in our assay system. The ef-
fects of cytochalasin D treatment suggest that dynamic actin
in the cytosol mediates L1CAM retrograde movement. In
combination with the velocity and direction of retrograde
movement, these results strongly suggest that L1CAM, like
other cell surface glycoproteins, associates with treadmilling
actin in the lamella of the cell (Fig. 8 B, I; Felsenfeld et al.,
1996; Suter et al., 1998; Lambert et al., 2002). However,
the observed decrease in retrograde movement after nocada-
zole treatment raises the possibility that microtubules may
also play some part in this process. Conditions that inhibit
ankyrin binding, including L1-YH mutants, consistently
stimulate retrograde movement, suggesting that ankyrin is
not the primary adaptor in this process. In contrast, station-
ary behavior is independent of dynamic actin and microtu-
bules, suggesting that a distinct cytoskeletal pool, perhaps
the membrane skeleton, serves as a transient attachment site
for L1CAM in the cytosol (Fig. 8 B, III). Mutations and
treatments that inhibit or block ankyrin binding including
L1-YH, growth factors, and the AP-YF peptide all inhibit
stationary behavior of L1CAM, indicating that ankyrin
binding to the FIGQY motif in L1CAM plays a primary
role in this process.
Analyses of L1CAM and L1 family members provide a list
of potential candidates for adaptor proteins mediating retro-
grade movement. The ankyrin binding site in neurofascin,
when phosphorylated, serves as a target for the protein dou-
blecortin (Kizhatil et al., 2002). Directed movement can be
detected in L1-YF mutants that are likely to be deficient in
doublecortin binding (Kizhatil et al., 2002). Therefore, it is
unlikely that doublecortin contributes to the retrograde
movement of L1CAM. A distinct phosphorylation site in
the L1CAM cytoplasmic tail (YRSLE) upstream of the
ankyrin site binds both the  2 chain of the AP-2 clathrin
complex (Schaefer et al., 2002) and ERM proteins (Dickson
et al., 2002). Although binding to AP-2 plays a critical role
in the endocytosis and recycling of L1CAM at the back of
the growth cone (Kamiguchi and Yoshihara, 2001), inhibi-
tion of the clathrin complex protein  -adaptin has no signif-
icant effect on L1CAM interactions with force-generating
components of the cytoskeleton, as detected by the move-
ment of L1CAM-bound beads on the cell surface (Kamigu-
chi and Yoshihara, 2001). However, in light of their known
interaction with actin (Bretscher et al., 2002), ERM proteins
remain potential candidates as adaptors between L1CAM
and treadmilling actin.
The anti-coordinate regulation of retrograde and station-
ary behavior by ankyrin binding has important implications
for the function of L1CAM in live cells. Although it is rea-
sonable to assume that ankyrin binding modulates the activ-
ity of an independent cytoskeletal adaptor protein responsi-
ble for the interaction between L1CAM and treadmilling
actin, the mechanism underlying this regulation has not
been determined. First, ankyrin could serve as a competitive
inhibitor for a distinct adaptor protein that binds at the same
site on L1CAM. Although it is unlikely that doublecortin
mediates L1CAM retrograde movement, we cannot preclude
the existence of other proteins that bind at or near the
FIGQY motif in the L1CAM tail. Second, ankyrin binding
could induce a change in the conformation of the L1CAM
tail that inhibits interactions with other adaptor proteins at a
distance. Finally, the L1CAM tail may serve as a mechanical
integrator of traction forces and as the restraining force pro-
vided by ankyrin binding (Fig. 8 B, II). According to this
model, ankyrin binding would retard the movement of
L1CAM being dragged backward through the membrane
through an indirect interaction with treadmilling actin.
Previous work focusing on traction-force generation alone
has shed little light on how cells regulate the transition be-
tween adhesion and migration (Felsenfeld et al., 1996;
Choquet et al., 1997), a common occurrence in vivo. The
experiments described here raise the possibility that the
modulation of adhesion receptor–cytoskeleton interactions
plays an essential role in the regulation of cell migration and
adhesion by effecting changes in the capacity of these pro-
teins to transfer traction forces to the extracellular environ-
ment. Moreover, the observation of a single receptor with
three discrete kinetic behaviors on the cell surface is, to the
best of our knowledge, entirely novel. The versatility of
L1CAM in this respect may reflect a critical feature of the
biology of L1CAM; the repertoire of L1 family members is
relatively limited compared with other families of adhesion
receptors (e.g., integrins, cadherins). Therefore, modulation
of L1CAM-mediated neuronal growth may require post-
translational regulation rather than a change in receptor ex-
pression. This type of direct modulation would also provide
a means for rapidly promoting or arresting cell movement,
which may be required during axon guidance. The capacity
of a single cytosolic interaction to modulate the function of
a receptor between static adhesion and traction-force genera-
tion raises the possibility that ankyrin binding may serve as a
master switch for L1 function in these two classes of cell be-
havior, an idea that is strongly supported by the nerve
growth–promoting properties of the inhibitory peptide.
This form of direct modulation has important implications
for the regulation of the shift from nerve growth to static ad-
hesion during neural development.
Materials and methods
cDNA constructs
cDNA encoding full-length rat L1CAM including the neuron-specific RSLE
exon were a gift of A. Furley (University of Sheffield, Sheffield, UK). The
cDNA was modified by PCR to include a 10-aa myc epitope (EQKLISEEDL)
4 aa after the predicted amino terminus of the mature protein (IPDEQKLI-
SEEDLYKGHH; inserted aa’s indicated in bold case). The insertion is up-
stream of mini-exon 2, which has been shown to play a role in L1CAM
binding to neural ligands (De Angelis et al., 2001). Mutations in the cyto-
plasmic tail were introduced by PCR using the QuikChange
® protocol
(Stratagene). Substitutions at tyrosine 1229 were effected by replacing
codon TAC with either TTC (Y to F) or CAC (Y to H). All constructs were
expressed using the bicistronic vector pIRES2-EGFP (CLONTECH Labora-
tories, Inc.).
L1CAM-GFP was generated by linking GFP2 (PerkinElmer) in frame to
the carboxy terminus of the full-length wild-type L1CAM construct by PCR.
Ankyrin cell membrane recruitment assay
Constructs encoding full-length wild-type L1CAM including the RSLE
mini-exon and either by an amino-terminal myc-epitope tag or by a car-
boxy-terminal GFP tag (see cDNA constructs above) were introduced byT
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LipofectAMINE™ plus (Invitrogen) transfection into human kidney 293
cells. Cells were used 24–48 h after transfection or as stable pooled lines of
L1CAM-expressing cells. L1CAM expression was detected by indirect im-
munofluorescence using an antibody against either L1CAM (rabbit anti-
L1CAM; gift of Carl Lagenaur, University of Pittsburgh, Pittsburgh, PA), by
9E10 (mouse anti-myc; Developmental Studies Hybridoma Bank, Univer-
sity of Iowa, Iowa City, IA), or by GFP distribution. In all cases, the results
were indistinguishable. Ankyrin B was detected by indirect immunofluo-
rescence using a mouse mAb (BD Biosciences). Confocal micrographs
(Olympus) were collected at a plane intersecting cell–cell junctions. Con-
trol images collected by exciting fluorophores with the inappropriate laser
line revealed no detectable crosstalk between channels.
Images were analyzed using NIH ImageJ (National Institutes of Health
(NIH), Bethesda, MD) under Macintosh OSX. Densitometry was performed
using a 5 pixel-wide line scan normal to the interface between two L1CAM-
positive cells. Signal maximum for ankyrin staining at junction between
cells was determined at the position of the maximal L1CAM staining to en-
sure that we were quantifying membrane rather that juxtamembrane stain-
ing. Minima were determined from the regions of the line overlapping the
cytoplasm of either of the two cells. Membrane localization index was de-
termined using the equation index   max/(max min) (Oancea et al., 1998).
Immunofluorescence
For immunolocalization, cells were fixed for 10 min using 1% PFA in 60
mM Pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM MgCl2 (PHEM;
Schliwa and van Blerkom, 1981). Staining was performed as described previ-
ously (Felsenfeld et al., 1999). Micrographs were collected on a micro-
scope (Axiovert 100TV; Carl Zeiss MicroImaging, Inc.) using a 100  plan
neofluor objective (NA 1.4). Antigens were detected by indirect immuno-
fluorescence using primary antibodies described in figure legends and sec-
ondary antibodies (either donkey anti–rabbit or donkey anti–mouse) con-
jugated to indocarbocyanin Cy3 (Jackson ImmunoResearch Laboratories).
Micrographs were collected using a cooled CCD camera (CoolSNAP
HQ™; Roper Scientific) under the control of ISee imaging software (ISee
Imaging Systems). Images were subsequently processed in Photoshop
®
(Adobe) to maximize contrast, and were subject to an unsharp mask.
Antennapedia peptides
Inhibitory peptides were generated as a fusion between the 16-aa penetra-
tin domain of antennapedia at the amino end and the ankyrin-binding
domain of L1CAM with the carboxy-terminal tyrosine modified to phenyl-
alanine (inhibitory peptide sequence RQIKIWFQNRRMKWKKQFNEDGS-
FIGQF). Control peptides were identical with a reversed ankyrin-binding
domain (control peptide sequence RQIKIWFQNRRMKWKKFQGIFSGDE-
NFQ). Both peptides included an amino-terminal biotin. Peptides were
synthesized by FastMoc chemistry (Tufts University Core Facility, Boston,
MA) and purified by HPLC yielding  97% purity as determined by mass
spectrometry. Peptides were dissolved in HBSS at 1 mg/ml and diluted
into cell culture medium at a final concentration of 1.4  g/ml.
Bead preparation
Beads were prepared as described previously (Choquet et al., 1997;
Felsenfeld et al., 1999). 1- m carboxylated latex microspheres (Poly-
science) were covalently coupled to ovalbumin (fraction VII; Sigma-
Aldrich) using a carbodiimide linkage to neutralize the bead surface. Oval-
bumin-coated beads were derivatized with Sulpho-NHS-LC-biotin (Pierce
Chemical Co.). Beads at this stage were used fresh or stored for up to 2 wk
at 4 C. Biotinylated beads were subsequently incubated with an excess of
neutravidin (Molecular Probes, Inc.) overnight at 4 C. Beads were washed
extensively, and a 15- l aliquot (based on starting concentration) was in-
cubated with biotinylated 9E10 antibody for 1 h (at RT) or overnight (at
4 C). Unreacted sites were blocked with biotin-BSA (BSA-biotinamidoca-
proyl; Sigma-Aldrich). Beads were sonicated for 5 s in a 0 C bath sonicator
before experiments.
Cell culture and transfection
Neuroblastoma/DRG hybrid cells (ND-7) were transfected with constructs
encoding either wild-type or mutant forms of L1CAM expressed in a bicis-
tronic vector encoding EGFP after an internal ribosomal entry site (pIRES2-
EGFP; CLONTECH Laboratories, Inc.). ND-7 cells were plated in L15 buff-
ered for CO2 (supplemented with 1:1:2 glucose/glutamine/Pen-Strep and
with dimethlytetrahydropterine, glutathione, and ascorbic acid; Cell and
Molecular Technologies) containing 10% bovine calf serum (Hyclone) on
coverslips 24 h before transfection. For video microscopy, medium was
replaced before moving cells to the microscope with phenol red–free,
serum-free L15 (air buffered) with 20 mM Hepes, 0.1% BSA, and 0.5%
ovalbumin. Coverslips were silanized and laminin-coated for video
microscopy as described previously (Felsenfeld et al., 1996). Alternatively,
cells were plated on coverslips coated with poly-D-lysine and laminin
sealed to the bottom of 35-mm culture dishes (MatTek Corporation). Trans-
fections were performed using LipofectAMINE™ plus (Invitrogen), and
cells were used 24–36 h later either live for video microscopy or fixed for
immunohistochemistry.
Video microscopy, laser tweezers, and data analysis
Video microscopy was performed largely as described previously (Felsen-
feld et al., 1999). All experiments were performed on a microscope (Axio-
vert 100 TV; Carl Zeiss MicroImaging, Inc.). Cells on laminin-coated cov-
erslips were cultured in sealed chambers permitting illumination with a
high resolution, oil immersion condenser. Images were collected and laser
trap formed through a 100  plan neofluor NA 1.4 objective. The laser trap
consisted of a Titanium Sapphire laser (model 890; Coherent) pumped by a
5-W Neodymium Vanadate laser (Coherent; Verdi) and tuned to 800 nm.
Laser power at the output of the Ti:Sapp was 40 mW, and beads were
placed and held on the cell surface for  3 s to further reduce the possibil-
ity of heating artifacts. Video images were collected using a Newvicon
camera (VE-1000N; Dage MTI), and were subsequently digitized onto an
Intel processor-based computer running the ISee software (ISee Imaging)
for quantification. Diffusion analysis was performed using a custom
spreadsheet in Excel (Microsoft). Individual traces were scored blind for
classes of behavior. Statistical analysis of percentages of trials was per-
formed using chi-squared analysis or a Fisher’s exact probability test (Fig. 6
B). For cytoskeleton attachment assays (Fig. 2), beads were retested with a
second pulse from the laser trap applied 0.5  m from the bead center. Lat-
eral movement of beads  0.2  m was scored as rigidly attached.
Neurite outgrowth assays
For neurite outgrowth assays, 50  g/ml purified chick NgCAM or 100  g/
ml mouse laminin (Invitrogen) was spotted on a 35-mm plastic culture dish
at RT for 1 h. After washing with PBS, the plastic surface was blocked with
1% BSA/PBS at RT. Cerebellar cells were prepared from postnatal day 4
(P4) mouse by trypsinization followed by trituration. Cells were resus-
pended in BME/B27 with Pen/Strep (GIBCO BRL) at 5   10
5 cells/ml, and
250  l was plated on the dishes. Cultures were incubated at 37 C for 24 h
in 5% CO2. Antennapedia peptides dissolved in HBSS (GIBCO BRL) were
added to the cultures at final concentration of 30  g/ml when cells were
plated. Cultures were fixed with 4% PFA, and images were captured as de-
scribed earlier in Materials and methods. Neurite outgrowth measurements
were performed by NIH image software and processed with Microsoft Ex-
cel. P values were determined using t test analysis.
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